uniQure Announces Presentations at Upcoming March Conferences
March 01 2017 - 7:00AM
uniQure N.V. (NASDAQ:QURE), a leading gene therapy company
advancing transformative therapies for patients with severe medical
needs, today announced presentations at the following conferences
taking place in March:
37th Annual Cowen & Co. Healthcare
Conference, at the Boston Marriott Copley Place, in Boston
Massachusetts.
- Matthew Kapusta, chief executive officer, will present on
Wednesday, March 8th at 10.00 a.m. EST. The live webcast can be
accessed through the link displayed in the Investor section of the
uniQure website at:
http://uniqure.com/investors-newsroom/events-presentations.php. The
webcast replay will be available for at least two weeks following
the live event.
Oppenheimer 27th Annual Healthcare
Conference, at the Westin New York Grand Central, in New York City.
- Matthew Kapusta, chief executive officer, will participate in a
Fireside Chat with analyst Hartaj Singh on Tuesday March 21st at
3.55 p.m. EST. The live webcast can be accessed through the link
displayed in the Investor section of the uniQure website at:
http://uniqure.com/investors-newsroom/events-presentations.php. The
webcast replay will be available for at least two weeks following
the live event.
11th Annual Symposium of the Coalition
for Hemophilia B, at the Sawgrass Marriott Golf Resort in Ponte
Vedra, Florida.
- uniQure will be exhibiting throughout the conference from
Friday March 31st to Sunday April 2nd.
About uniQure uniQure is
delivering on the promise of gene therapy – single treatments with
potentially curative results. We are leveraging our modular and
validated technology platform to rapidly advance a pipeline of
proprietary and partnered gene therapies to treat patients with
hemophilia, Huntington’s disease and cardiovascular diseases.
www.uniQure.com
uniQure Contacts:
Maria E. Cantor
Direct: 339-970-7536
Mobile: 617-680-9452
m.cantor@uniQure.com
Tom Malone
Direct: 339-970-7558
Mobile: 339-223-8541
t.malone@uniQure.com
Eva M. Mulder
Direct: +31 20 240 6103
Mobile: +31 6 52 33 15 79
e.mulder@uniQure.com
uniQure NV (NASDAQ:QURE)
Historical Stock Chart
From Jun 2024 to Jul 2024
uniQure NV (NASDAQ:QURE)
Historical Stock Chart
From Jul 2023 to Jul 2024